What is Chevron Corporation's earnings per share (EPS)?

Chevron Corporation (CVX) reported diluted earnings per share of $6.63 for fiscal year 2025. This represents a -31.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Chevron Corporation (CVX) Financials

CVX

Trailing 12 months to June 30, 2026

Revenue $215.3B +10.2% YoY

Net Income $20.6B +49.7% YoY

EPS (Diluted) $10.40 +33.8% YoY

Free Cash Flow $27.0B +67.8% YoY

Market Cap $406.2B as of Oct 2, 2026

Price / Sales 1.9x on $215.3B revenue, trailing 12 months to June 30, 2026

Price / Earnings 19.7x on $20.6B net income, trailing 12 months to June 30, 2026

Price / Book 2.1x on $189.9B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CVX SEC filings page.

Chevron Corporation (CVX) reported $215.3B in revenue over the twelve months to Jun 30, 2026, up 10.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CVX FY2025 2026-08-30

Chevron’s 2025 profile is a capital-intensive cash generator whose balance-sheet expansion outpaced earnings.

The cash conversion gap widened: net income fell 30.5% from FY2024 while operating cash flow rose 7.8%, indicating that 2025 cash generation was less tied to reported profit than the income statement alone suggests. Free cash flow reached $16.6B against capital reinvestment of $17.3B, showing cash remained positive after substantial spending on the asset base.

The margin shape weakened: revenue contracted in FY2025 while net margin fell from 8.7% to 6.5%, indicating the pressure reached profitability rather than staying at the top line. SG&A rose to $5.1B even as revenue contracted, suggesting the expense base was not reduced in step with activity.

The balance-sheet posture changed materially: total assets rose 26.1% to $324B, enlarging the capital base even as earnings weakened. Debt/equity climbed to 0.2x from 0.1x, so the expansion was funded with a more leveraged mix rather than solely by accumulated equity.

Financial Health Signals

Financial Health Score 37/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Chevron Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Chevron Corporation, and counted as zero in the overall score.

Growth

Chevron Corporation's revenue declined 6.8% year-over-year, from $202.8B to $189.0B. This contraction results in a growth score of 37/100.

Leverage

Chevron Corporation carries a low D/E ratio of 0.21, meaning only $0.21 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 74/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Chevron Corporation's current ratio of 1.15 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Chevron Corporation converts 8.8% of revenue into free cash flow ($16.6B). This strong cash generation earns a score of 68/100.

Returns

Not available for Chevron Corporation, and counted as zero in the overall score.

Piotroski F-Score Partial

4/8

Chevron Corporation passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.76x

For every $1 of reported earnings, Chevron Corporation generates $2.76 in operating cash flow ($33.9B OCF vs $12.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$70.1B

YoY+56.3%

QoQ+44.1%

5Y CAGR+13.3%

10Y CAGR+9.1%

Chevron Corporation generated $70.1B in revenue in Q2 2026. This represents an increase of 56.3% from the same quarter a year earlier. Against the prior quarter it is up 44.1%.

Net Income

$12.1B

YoY+384.8%

QoQ+446.2%

5Y CAGR+31.4%

Chevron Corporation reported $12.1B in net income in Q2 2026. This represents an increase of 384.8% from the same quarter a year earlier. Against the prior quarter it is up 446.2%.

EPS (Diluted)

$6.11

YoY+321.4%

QoQ+450.5%

5Y CAGR+30.7%

Chevron Corporation earned $6.11 per diluted share (EPS) in Q2 2026. This represents an increase of 321.4% from the same quarter a year earlier. Against the prior quarter it is up 450.5%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$18.1B

YoY+272.0%

QoQ+1268.2%

5Y CAGR+28.5%

Chevron Corporation generated $18.1B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 272.0% from the same quarter a year earlier. Against the prior quarter it is up 1268.2%.

Cash & Debt

$9.6B

YoY+78.3%

QoQ+51.7%

5Y CAGR+4.9%

10Y CAGR+0.9%

Chevron Corporation held $9.6B in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$1.78

YoY+4.1%

QoQ0.0%

5Y CAGR+5.8%

Chevron Corporation paid $1.78 per share in dividends in Q2 2026. This represents an increase of 4.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

1.98B

YoY+14.3%

QoQ-0.8%

5Y CAGR+0.4%

10Y CAGR+0.5%

Chevron Corporation had 1.98B shares outstanding in Q2 2026. This represents an increase of 14.3% from the same quarter a year earlier. Against the prior quarter it is down 0.8%.

Margins & Returns

Net Margin

17.2%

YoY+11.7pp

QoQ+12.7pp

5Y change+9.0pp

10Y change+22.3pp

Chevron Corporation's net profit margin was 17.2% in Q2 2026, showing the share of revenue converted to profit. This is up 11.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.7 percentage points.

Return on Equity

6.4%

YoY+4.7pp

QoQ+5.2pp

5Y change+4.1pp

10Y change+7.4pp

Chevron Corporation's ROE was 6.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.2 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$3.0B

YoY+15.6%

QoQ+16.8%

5Y CAGR+331.8%

Chevron Corporation spent $3.0B on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 15.6% from the same quarter a year earlier. Against the prior quarter it is up 16.8%.

Capital Expenditures

$4.5B

YoY+22.3%

QoQ+11.7%

5Y CAGR+20.4%

10Y CAGR+0.2%

Chevron Corporation invested $4.5B in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 22.3% from the same quarter a year earlier. Against the prior quarter it is up 11.7%.

R&D Spending

Not reported for Q2 2026.

CVX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$215.3B	$189.0B-6.8%	$202.8B+0.9%	$200.9B-18.4%	$246.3B+51.6%	$162.5B+71.6%	$94.7B-35.4%	$146.5B-11.9%	$166.3B+17.4%	$141.7B+23.8%	$114.5B-17.3%	$138.5B-34.7%	$212.0B-7.4%	$228.8B-5.4%	$241.9B-4.6%	$253.7B
Cost of Revenue	$117.6B	$108.2B-9.2%	$119.2B0.0%	$119.2B-18.0%	$145.4B+57.6%	$92.2B+76.9%	$52.1B-34.9%	$80.1B-15.3%	$94.6B+24.8%	$75.8B+27.7%	$59.3B	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$427.0M+21.0%	$353.0M+10.3%	$320.0M+19.4%	$268.0M0.0%	$268.0M-38.4%	$435.0M-13.0%	$500.0M+10.4%	$453.0M+4.6%	$433.0M-9.0%	$476.0M-20.8%	$601.0M-15.0%	$707.0M-5.7%	$750.0M+15.7%	$648.0M+3.3%	$627.0M
SG&A Expenses	$5.4B	$5.1B+6.0%	$4.8B+16.7%	$4.1B-4.0%	$4.3B+7.4%	$4.0B-4.7%	$4.2B+1.7%	$4.1B+7.9%	$3.8B-6.6%	$4.1B-4.5%	$4.3B-3.1%	$4.4B-1.1%	$4.5B-0.4%	$4.5B-4.5%	$4.7B-0.4%	$4.7B
Interest Expense	$1.4B	$1.2B+104.9%	$594.0M+26.7%	$469.0M-9.1%	$516.0M-27.5%	$712.0M+2.2%	$697.0M-12.7%	$798.0M+6.7%	$748.0M+143.6%	$307.0M+52.7%	$201.0M	$0	$0	$0	$0	$0
Income Tax	$9.7B	$7.3B-25.6%	$9.8B+19.4%	$8.2B-41.9%	$14.1B+136.4%	$6.0B+414.5%	-$1.9B-170.3%	$2.7B-52.9%	$5.7B+12006.3%	-$48.0M+97.2%	-$1.7B-1409.8%	$132.0M-98.9%	$11.9B-16.9%	$14.3B-28.4%	$20.0B-3.1%	$20.6B
Net Income	$20.6B	$12.3B-30.5%	$17.7B-17.3%	$21.4B-39.7%	$35.5B+127.6%	$15.6B+381.4%	-$5.5B-289.6%	$2.9B-80.3%	$14.8B+61.2%	$9.2B+1950.1%	-$497.0M-110.8%	$4.6B-76.2%	$19.2B-10.2%	$21.4B-18.2%	$26.2B-2.7%	$26.9B
EPS (Basic)	N/A	$6.65-31.9%	$9.76-14.5%	$11.41-37.9%	$18.36+125.3%	$8.15+375.3%	-$2.96-291.0%	$1.55-80.2%	$7.81+60.0%	$4.88+1907.4%	-$0.27-111.0%	$2.46-75.9%	$10.21-8.7%	$11.18-16.7%	$13.42-0.9%	$13.54
EPS (Diluted)	$10.40	$6.63-31.8%	$9.72-14.4%	$11.36-37.9%	$18.28+124.6%	$8.14+375.0%	-$2.96-292.2%	$1.54-80.1%	$7.74+59.6%	$4.85+1896.3%	-$0.27-111.0%	$2.45-75.8%	$10.14-8.6%	$11.09-16.7%	$13.32-0.9%	$13.44
Diluted Shares (Avg)	N/A	1.86B+2.1%	1.82B-3.4%	1.88B-3.1%	1.94B+1.0%	1.92B+2.7%	1.87B-1.3%	1.90B-1.0%	1.91B+0.8%	1.90B+1.3%	1.87B-0.1%	1.88B-1.2%	1.90B-1.8%	1.93B-1.7%	1.97B-1.8%	2.00B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$70.1B+56.3%	$48.6B+2.1%	$46.9B-10.2%	$49.7B-1.9%	$44.8B-12.4%	$47.6B-2.3%	$52.2B+10.7%	$50.7B-6.3%
Cost of Revenue	$36.6B+36.3%	$28.3B-1.2%	$25.3B-15.9%	$27.4B-10.0%	$26.9B-13.0%	$28.6B+3.1%	$30.1B+5.9%	$30.4B-5.8%
SG&A Expenses	$1.3B+47.8%	$1.1B-12.7%	$1.5B-5.9%	$1.5B+28.0%	$889.0M-15.2%	$1.2B+20.9%	$1.6B+63.6%	$1.2B+2.4%
Interest Expense	$352.0M+28.5%	$345.0M+62.7%	$361.0M+81.4%	$370.0M+125.6%	$274.0M+142.5%	$212.0M+79.7%	$199.0M+65.8%	$164.0M+43.9%
Income Tax	$4.5B+173.9%	$1.7B-20.2%	$1.8B-37.4%	$1.8B-9.6%	$1.6B-37.1%	$2.1B-12.7%	$2.8B+124.5%	$2.0B-8.7%
Net Income	$12.1B+384.8%	$2.2B-36.9%	$2.8B-15.5%	$3.5B-21.1%	$2.5B-43.8%	$3.5B-36.4%	$3.3B+43.1%	$4.5B-31.2%
EPS (Basic)	$6.13+322.8%	$1.12-44.3%	$1.36-26.5%	$1.83-26.5%	$1.45-40.3%	$2.01-32.8%	$1.85+50.4%	$2.49-28.4%
EPS (Diluted)	$6.11+321.4%	$1.11-44.5%	$1.36-26.1%	$1.82-26.6%	$1.45-40.3%	$2.00-32.7%	$1.84+50.8%	$2.48-28.7%
Diluted Shares (Avg)	1.98B+14.5%	1.99B+13.4%	N/A	1.95B+7.7%	1.72B-5.9%	1.75B-5.3%	N/A	1.81B-3.7%

Not reported in any period shown, so not listed: Gross Profit, R&D Expenses, Operating Income, EBITDA.

CVX Balance Sheet

CVX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$324.0B+26.1%	$256.9B-1.8%	$261.6B+1.5%	$257.7B+7.6%	$239.5B-0.1%	$239.8B+1.0%	$237.4B-6.5%	$253.9B0.0%	$253.8B-2.4%	$260.1B-1.7%	$264.5B-0.6%	$266.0B+4.8%	$253.8B+8.9%	$233.0B+11.2%	$209.5B
Current Assets	$38.6B-5.8%	$40.9B-0.5%	$41.1B-18.3%	$50.3B+49.2%	$33.7B+29.4%	$26.1B-7.9%	$28.3B-16.7%	$34.0B+19.1%	$28.6B-3.6%	$29.6B-14.0%	$34.4B-18.5%	$42.2B-16.0%	$50.3B-9.8%	$55.7B+4.7%	$53.2B
Cash & Equivalents	$7.3B-11.8%	$8.3B+1.0%	$8.2B-53.7%	$17.7B+213.4%	$5.6B+0.8%	$5.6B-19.0%	$6.9B-26.0%	$9.3B+94.1%	$4.8B-31.1%	$7.0B-36.6%	$11.0B-13.8%	$12.8B-21.3%	$16.2B-22.4%	$20.9B+32.0%	$15.9B
Short-Term Investments	$0	$0-100.0%	$45.0M-79.8%	$223.0M+537.1%	$35.0M+12.9%	$31.0M-50.8%	$63.0M+18.9%	$53.0M+488.9%	$9.0M-30.8%	$13.0M-95.8%	$310.0M-26.5%	$422.0M+60.5%	$263.0M-1.1%	$266.0M+6.8%	$249.0M
Inventory	$9.7B+7.0%	$9.1B+5.4%	$8.6B+4.4%	$8.2B+21.4%	$6.8B+19.7%	$5.7B-2.9%	$5.8B+2.5%	$5.7B+2.1%	$5.6B+3.1%	$5.4B-14.4%	$6.3B-2.6%	$6.5B+2.0%	$6.4B+3.8%	$6.1B+10.8%	$5.5B
Accounts Receivable	$16.0B-12.8%	$18.3B+4.0%	$17.6B-3.1%	$18.2B+11.0%	$16.4B+72.6%	$9.5B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.6B-0.2%	$4.6B-3.0%	$4.7B0.0%	$4.7B+7.7%	$4.4B-0.4%	$4.4B-1.4%	$4.5B-1.2%	$4.5B-0.3%	$4.5B-1.1%	$4.6B-0.2%	$4.6B-0.1%	$4.6B-1.0%	$4.6B0.0%	$4.6B0.0%	$4.6B
Total Liabilities	$131.8B+27.0%	$103.8B+4.1%	$99.7B+2.3%	$97.5B-2.1%	$99.6B-7.0%	$107.1B+16.1%	$92.2B-6.1%	$98.2B-6.0%	$104.5B-7.8%	$113.4B+2.4%	$110.7B+0.7%	$109.8B+6.3%	$103.3B+8.6%	$95.2B+9.0%	$87.3B
Current Liabilities	$33.4B-13.4%	$38.6B+19.5%	$32.3B-5.7%	$34.2B+27.7%	$26.8B+20.8%	$22.2B-16.4%	$26.5B-2.4%	$27.2B-2.0%	$27.7B-12.7%	$31.8B+24.8%	$25.5B-20.2%	$31.9B-3.3%	$33.0B-3.5%	$34.2B+1.8%	$33.6B
Non-Current Liabilities	$98.4B+50.9%	$65.2B-3.3%	$67.4B+6.6%	$63.3B-13.1%	$72.8B-14.2%	$84.9B+29.2%	$65.7B-7.5%	$71.0B-7.4%	$76.8B-5.9%	$81.6B-4.2%	$85.2B+9.3%	$77.9B+10.8%	$70.3B+15.4%	$60.9B+13.5%	$53.7B
Long-Term Debt	$39.8B+97.6%	$20.1B-0.8%	$20.3B-5.0%	$21.4B-31.3%	$31.1B-27.2%	$42.8B+80.5%	$23.7B-17.5%	$28.7B-14.2%	$33.5B-4.9%	$35.2B+4.9%	$33.5B+40.0%	$24.0B+20.0%	$20.0B+66.8%	$12.0B+23.6%	$9.7B
Total Equity	$186.4B+22.4%	$152.3B-5.4%	$161.0B+1.1%	$159.3B+14.5%	$139.1B+5.6%	$131.7B-8.7%	$144.2B-6.7%	$154.6B+4.3%	$148.1B+1.8%	$145.6B-4.7%	$152.7B-1.5%	$155.0B+4.0%	$149.1B+9.2%	$136.5B+12.5%	$121.4B
Retained Earnings	$205.4B-0.2%	$205.9B+2.9%	$200.0B+5.3%	$190.0B+14.8%	$165.5B+3.2%	$160.4B-8.3%	$174.9B-3.3%	$181.0B+4.0%	$174.1B+0.6%	$173.0B-4.7%	$181.6B-1.8%	$185.0B+6.5%	$173.7B+8.7%	$159.7B+13.8%	$140.4B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$330.1B+31.6%	$329.6B+28.5%	$324.0B+26.1%	$326.5B+25.9%	$250.8B-3.8%	$256.4B-2.0%	$256.9B-1.8%	$259.2B-1.8%
Current Assets	$49.1B+41.6%	$46.2B+19.7%	$38.6B-5.8%	$40.9B+7.0%	$34.7B-11.9%	$38.6B-4.8%	$40.9B-0.5%	$38.2B-8.5%
Cash & Equivalents	$9.6B+78.3%	$6.3B+2.4%	$7.3B-11.8%	$8.8B+52.4%	$5.4B+34.1%	$6.2B-1.8%	$8.3B+1.0%	$5.8B-0.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0-100.0%	$0-100.0%
Inventory	$10.5B+19.4%	$10.6B+15.1%	$9.7B+7.0%	$10.4B+7.3%	$8.8B-15.9%	$9.2B-7.8%	$9.1B+5.4%	$9.7B+3.2%
Accounts Receivable	$22.0B+40.1%	$22.2B+29.1%	$16.0B-12.8%	$16.0B-7.5%	$15.7B-14.2%	$17.2B-4.4%	$18.3B+4.0%	$17.3B-11.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.6B0.0%	$4.6B0.0%	$4.6B-0.2%	$4.6B-3.3%	$4.6B-3.3%	$4.6B-3.3%	$4.6B-3.0%	$4.7B0.0%
Total Liabilities	$134.6B+29.9%	$140.2B+31.9%	$131.8B+27.0%	$130.9B+28.1%	$103.6B+3.2%	$106.3B+6.3%	$103.8B+4.1%	$102.2B+4.6%
Current Liabilities	$39.2B+12.7%	$42.2B+18.1%	$33.4B-13.4%	$35.5B-0.7%	$34.8B+2.4%	$35.7B+8.4%	$38.6B+19.5%	$35.7B+7.4%
Non-Current Liabilities	$95.3B+38.7%	$98.0B+38.8%	$98.4B+50.9%	$95.4B+43.5%	$68.7B+3.6%	$70.6B+5.3%	$65.2B-3.3%	$66.5B+3.2%
Long-Term Debt	N/A	N/A	$39.8B+97.6%	N/A	N/A	N/A	$20.1B-0.8%	N/A
Total Equity	$189.9B+29.7%	$183.7B+23.1%	$186.4B+22.4%	$189.8B+21.5%	$146.4B-8.0%	$149.2B-7.1%	$152.3B-5.4%	$156.2B-5.5%
Retained Earnings	$212.6B+3.2%	$204.0B-1.1%	$205.4B-0.2%	$206.0B+0.2%	$205.9B+1.0%	$206.4B+1.9%	$205.9B+2.9%	$205.5B+2.4%

CVX Cash Flow Statement

CVX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$45.3B	$33.9B+7.8%	$31.5B-11.6%	$35.6B-28.2%	$49.6B+69.9%	$29.2B+175.9%	$10.6B-61.3%	$27.3B-10.8%	$30.6B+50.5%	$20.3B+60.3%	$12.7B-34.8%	$19.5B-38.2%	$31.5B-10.1%	$35.0B-9.8%	$38.8B-5.6%	$41.1B
Depreciation & Amortization	N/A	$20.1B+16.5%	$17.3B-0.3%	$17.3B+6.2%	$16.3B-9.0%	$17.9B-8.1%	$19.5B-33.2%	$29.2B+50.5%	$19.4B+0.4%	$19.3B-0.6%	$19.5B-7.5%	$21.0B+25.3%	$16.8B+18.4%	$14.2B+5.8%	$13.4B+3.9%	$12.9B
Capital Expenditures	$18.3B	$17.3B+5.5%	$16.4B+3.9%	$15.8B+32.2%	$12.0B+48.6%	$8.1B-9.7%	$8.9B-36.8%	$14.1B+2.3%	$13.8B+2.9%	$13.4B-26.0%	$18.1B-38.6%	$29.5B-16.7%	$35.4B-6.8%	$38.0B+22.8%	$30.9B+16.7%	$26.5B
Free Cash Flow	$27.0B	$16.6B+10.3%	$15.0B-23.9%	$19.8B-47.4%	$37.6B+78.1%	$21.1B+1176.8%	$1.7B-87.5%	$13.2B-21.6%	$16.8B+142.7%	$6.9B+228.0%	-$5.4B+46.1%	-$10.0B-155.5%	-$3.9B-31.8%	-$3.0B-137.9%	$7.9B-46.1%	$14.6B
Investing Cash Flow	-$14.1B	-$15.9B-78.1%	-$8.9B+41.3%	-$15.2B-25.8%	-$12.1B-106.4%	-$5.9B+15.8%	-$7.0B+39.2%	-$11.5B+6.8%	-$12.3B-47.7%	-$8.3B+49.2%	-$16.4B+31.2%	-$23.8B+20.4%	-$29.9B+16.1%	-$35.6B-43.6%	-$24.8B+9.8%	-$27.5B
Financing Cash Flow	-$27.0B	-$19.1B+18.8%	-$23.5B+22.0%	-$30.1B-20.5%	-$25.0B-8.1%	-$23.1B-518.7%	-$3.7B+81.1%	-$19.8B-44.2%	-$13.7B+5.9%	-$14.6B-58316.0%	$25.0M-99.1%	$2.8B+156.3%	-$5.0B-30.8%	-$3.8B+57.4%	-$9.0B+23.7%	-$11.8B
Dividends Paid	$13.9B	$12.8B+8.1%	$11.8B+4.1%	$11.3B+3.4%	$11.0B+7.8%	$10.2B+5.5%	$9.7B+7.7%	$9.0B+5.4%	$8.5B+4.5%	$8.1B+1.2%	$8.0B+0.5%	$8.0B+0.8%	$7.9B+6.1%	$7.5B+9.2%	$6.8B+11.5%	$6.1B
Share Buybacks	$11.1B	$12.1B-20.7%	$15.2B+1.9%	$14.9B+32.7%	$11.3B+713.8%	$1.4B-21.3%	$1.8B-56.5%	$4.0B+130.7%	$1.8B+175000.0%	$1.0M-50.0%	$2.0M0.0%	$2.0M-100.0%	$5.0B0.0%	$5.0B0.0%	$5.0B+17.4%	$4.3B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$22.6B+163.9%	$2.5B-51.6%	$10.8B+24.1%	$9.4B-3.0%	$8.6B+36.2%	$5.2B-24.0%	$8.7B-30.1%	$9.7B0.0%
Depreciation & Amortization	$6.1B+40.0%	$5.8B+40.9%	$5.9B+18.3%	$5.8B+37.2%	$4.3B+8.5%	$4.1B+0.8%	$5.0B-20.5%	$4.2B+4.7%
Capital Expenditures	$4.5B+22.3%	$4.1B+3.5%	$5.3B+21.3%	$4.4B+9.6%	$3.7B-6.4%	$3.9B-4.0%	$4.3B-0.5%	$4.1B-13.2%
Free Cash Flow	$18.1B+272.0%	-$1.5B-222.7%	$5.5B+26.8%	$4.9B-12.1%	$4.9B+108.8%	$1.3B-53.9%	$4.4B-46.0%	$5.6B+12.4%
Investing Cash Flow	-$4.3B-24.0%	-$3.0B+46.4%	-$4.9B-284.7%	-$1.9B+47.8%	-$3.4B+13.2%	-$5.6B-42.0%	$2.7B+165.6%	-$3.7B+16.2%
Financing Cash Flow	-$15.1B-152.2%	-$448.0M+73.1%	-$7.4B+16.1%	-$4.0B+23.2%	-$6.0B-31.1%	-$1.7B+65.8%	-$8.8B-42.4%	-$5.3B+39.0%
Dividends Paid	$3.5B+19.4%	$3.5B+18.2%	$3.4B+17.9%	$3.4B+16.9%	$2.9B-1.5%	$3.0B-0.6%	$2.9B+2.8%	$2.9B+2.8%
Share Buybacks	$3.0B+15.6%	$2.6B-34.3%	$3.0B-33.4%	$2.6B-46.0%	$2.6B-13.4%	$3.9B+31.5%	$4.5B+31.5%	$4.8B+40.1%

Not reported in any period shown, so not listed: Stock-Based Compensation.

CVX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	6.5%-2.2pp	8.7%-1.9pp	10.7%-3.8pp	14.4%+4.8pp	9.6%+15.4pp	-5.9%-7.8pp	2.0%-6.9pp	8.9%+2.4pp	6.5%+6.9pp	-0.4%-3.7pp	3.3%-5.8pp	9.1%-0.3pp	9.4%-1.5pp	10.8%+0.2pp	10.6%
Return on Equity	6.6%-5.0pp	11.6%-1.7pp	13.3%-9.0pp	22.3%+11.1pp	11.2%+15.4pp	-4.2%-6.2pp	2.0%-7.6pp	9.6%+3.4pp	6.2%+6.6pp	-0.3%-3.3pp	3.0%-9.4pp	12.4%-2.0pp	14.4%-4.8pp	19.2%-3.0pp	22.2%
Return on Assets	3.8%-3.1pp	6.9%-1.3pp	8.2%-5.6pp	13.8%+7.3pp	6.5%+8.8pp	-2.3%-3.5pp	1.2%-4.6pp	5.8%+2.2pp	3.6%+3.8pp	-0.2%-1.9pp	1.7%-5.5pp	7.2%-1.2pp	8.4%-2.8pp	11.2%-1.6pp	12.8%
Current Ratio	1.15+0.1x	1.06-0.2x	1.27-0.2x	1.47+0.2x	1.26+0.1x	1.18+0.1x	1.07-0.2x	1.25+0.2x	1.03+0.1x	0.93-0.4x	1.350.0x	1.32-0.2x	1.52-0.1x	1.630.0x	1.58
Debt-to-Equity	0.21+0.1x	0.130.0x	0.130.0x	0.13-0.1x	0.22-0.1x	0.32+0.2x	0.160.0x	0.190.0x	0.230.0x	0.240.0x	0.22+0.1x	0.150.0x	0.130.0x	0.090.0x	0.08
Asset Turnover	0.58-0.2x	0.790.0x	0.77-0.2x	0.96+0.3x	0.68+0.3x	0.39-0.2x	0.620.0x	0.66+0.1x	0.56+0.1x	0.44-0.1x	0.52-0.3x	0.80-0.1x	0.90-0.1x	1.04-0.2x	1.21
FCF Margin	8.8%+1.4pp	7.4%-2.4pp	9.8%-5.4pp	15.3%+2.3pp	13.0%+11.3pp	1.8%-7.3pp	9.0%-1.1pp	10.1%+5.2pp	4.9%+9.6pp	-4.7%+2.5pp	-7.3%-5.4pp	-1.8%-0.5pp	-1.3%-4.5pp	3.3%-2.5pp	5.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	17.2%+11.7pp	4.5%-2.8pp	5.9%-0.4pp	7.1%-1.7pp	5.6%-3.1pp	7.3%-3.9pp	6.3%+1.4pp	8.9%-3.2pp
Return on Equity	6.4%+4.7pp	1.2%-1.1pp	1.5%-0.7pp	1.9%-1.0pp	1.7%-1.1pp	2.4%-1.1pp	2.1%+0.7pp	2.9%-1.1pp
Return on Assets	3.7%+2.7pp	0.7%-0.7pp	0.9%-0.4pp	1.1%-0.6pp	1.0%-0.7pp	1.4%-0.7pp	1.3%+0.4pp	1.7%-0.7pp
Current Ratio	1.25+0.3x	1.090.0x	1.15+0.1x	1.15+0.1x	1.00-0.2x	1.08-0.1x	1.06-0.2x	1.07-0.2x
Debt-to-Equity	0.710.0x	0.76+0.1x	0.21+0.1x	0.690.0x	0.71+0.1x	0.71+0.1x	0.130.0x	0.65+0.1x
Asset Turnover	0.210.0x	0.150.0x	0.14-0.1x	0.150.0x	0.180.0x	0.190.0x	0.200.0x	0.200.0x
FCF Margin	25.8%+15.0pp	-3.2%-5.8pp	11.8%+3.5pp	9.9%-1.1pp	10.8%+6.3pp	2.6%-3.0pp	8.3%-8.8pp	11.1%+1.8pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Chevron Corporation CVX	FY2025	$189.0B	$12.3B	6.5%	$406.2B	37/100
ExxonMobil XOM	FY2025	$332.2B	$28.8B	8.7%	$669.2B	37/100
Shell SHEL	FY2025	$266.9B	$18.1B	6.8%	$270.9B	23/100
TotalEnergies SE TTE	FY2025	$201.2B	$13.4B	6.6%	$188.8B	22/100
BP p.l.c. BP	FY2025	$192.5B	$1.3B	0.7%	$113.3B	26/100
PETROLEO BRASILEIRO S.A.-PETROBRAS PBR	FY2025	$89.2B	$19.7B	22.1%	$134.5B	14/100

Where Chevron Corporation Ranks

Frequently Asked Questions

What is Chevron Corporation's annual revenue?

Chevron Corporation (CVX) reported $189.0B in total revenue for fiscal year 2025. This represents a -6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Chevron Corporation's revenue growing?

Chevron Corporation (CVX) revenue declined by 6.8% year-over-year, from $202.8B to $189.0B in fiscal year 2025.

Is Chevron Corporation profitable?

Yes, Chevron Corporation (CVX) reported a net income of $12.3B in fiscal year 2025, with a net profit margin of 6.5%.

How much debt does Chevron Corporation have?

As of fiscal year 2025, Chevron Corporation (CVX) had $7.3B in cash and equivalents against $39.8B in long-term debt.

What is Chevron Corporation's net profit margin?

Chevron Corporation (CVX) had a net profit margin of 6.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Chevron Corporation pay dividends?

Yes, Chevron Corporation (CVX) paid $6.84 per share in dividends during fiscal year 2025.

What is Chevron Corporation's return on equity (ROE)?

Chevron Corporation (CVX) has a return on equity of 6.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Chevron Corporation's free cash flow?

Chevron Corporation (CVX) generated $16.6B in free cash flow during fiscal year 2025. This represents a 10.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Chevron Corporation's operating cash flow?

Chevron Corporation (CVX) generated $33.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Chevron Corporation's total assets?

Chevron Corporation (CVX) had $324.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Chevron Corporation's capital expenditures?

Chevron Corporation (CVX) invested $17.3B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Chevron Corporation spend on research and development?

Chevron Corporation (CVX) invested $427.0M in research and development during fiscal year 2025.

Does Chevron Corporation buy back shares?

Yes, Chevron Corporation (CVX) spent $12.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Chevron Corporation have outstanding?

Chevron Corporation (CVX) had 2.00B shares outstanding as of fiscal year 2025.

What is Chevron Corporation's current ratio?

Chevron Corporation (CVX) had a current ratio of 1.15 as of fiscal year 2025, which is considered adequate.

What is Chevron Corporation's debt-to-equity ratio?

Chevron Corporation (CVX) had a debt-to-equity ratio of 0.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Chevron Corporation's return on assets (ROA)?

Chevron Corporation (CVX) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Chevron Corporation's P/E ratio?

Chevron Corporation (CVX) trades at 19.7x earnings, its market capitalization divided by net income of $20.6B net income, trailing 12 months to June 30, 2026. The market capitalization is $406.2B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Chevron Corporation's price-to-sales ratio?

Chevron Corporation (CVX) trades at 1.9x sales, its market capitalization divided by revenue of $215.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $406.2B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Chevron Corporation's Piotroski F-Score?

Chevron Corporation (CVX) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Chevron Corporation's earnings high quality?

Chevron Corporation (CVX) has an earnings quality ratio of 2.76x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Chevron Corporation?

Chevron Corporation (CVX) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.